Low Testosterone: FDA Panel Backs Limits on Drugs

low T

The New York Times reports that a panel of twenty medical experts voted for the Food and Drug Administration (FDA) to impose new limitations on the testosterone drug industry. The panel recommended that the agency tighten the labeling of these drugs so they are not prescribed to men who are only experiencing the effects of getting older, such as decreased energy and libido.
While the FDA is not required to do what the panel tells it to do, the agency usually follows the advice of such expert panels. Meanwhile there is increasing medical evidence that testosterone has serious side effects and can, in certain patients, cause serious injury including, potentially melanoma (serious skin cancer). JAMA Intern Med. 2014.

For questions about product liability for Low T (testosterone) drugs Click here to contact us for a confidential case review.